X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: What is IPAB, and why is it bad for patients?

By Nicole Longo  |    February 13, 2017
In 2017, the Independent Payment Advisory Board (IPAB)couldfinally go into effect and come between patients and their health care providers. This week, we’re looking into this dangerous body.     Read More

Medicare Monday: Did you know … ?

By Nicole Longo  |    February 6, 2017
On Medicare Monday, we talk a lot about Medicare Part D and how it works, but here are five things you might not know about the program.   Read More

Medicare Monday: How Part D helps patients with heart disease live longer, healthier lives

By Nicole Longo  |    January 30, 2017
Wednesday kicks off American Heart Month, so this week we’re looking at heart health and how important it is for patients to have access to needed medicines for heart disease and stroke. This is...   Read More

Medicare Monday: How Medicare helps beneficiaries access needed medicines

By Nicole Longo  |    January 23, 2017
Throughout 2016, we looked at how different groups of beneficiaries – from seniors to minority communities to individuals with lower-incomes – rely on Medicare to access their needed prescription...   Read More

Medicare Monday: A closer look at Medicare Part B

By Kelsey Lang  |    January 16, 2017
We took a deeper dive on Medicare Part D last week, so today we’re switching gears and talking about Medicare Part B.   Read More

Medicare Monday: A refresh on private negotiation in Part D

By Nicole Longo  |    January 9, 2017
Last week, we highlighted a number of Medicare resources – from how to learn more about which medicines are covered in Part B to how Part D has been a success since its implementation. And this...   Read More

Medicare Monday: Kicking off 2017 with Medicare resources

By Nicole Longo  |    January 2, 2017
Happy New Year, #MedicareMonday readers!   Read More

Medicare Monday: Looking back at the success of Part D in its first 10 years

By Nicole Longo  |    December 26, 2016
As 2016 comes to a close this week, Medicare Part D wraps up its first decade – and it’s been quite a busy decade. Today, more than 40 million people, including seniors and people living with...   Read More

Medicare Monday: New research finds trends in Average Sales Price of Part B drugs remains stable

By Kelsey Lang  |    December 19, 2016
Earlier this year, we looked at Average Sales Price (ASP) and how it works in Medicare Part B. As you may remember, ASP (the method for reimbursing drugs covered by Part B) is a market-based price...   Read More

Medicare Monday: Negotiation in Medicare Part D works

By Allyson Funk  |    December 12, 2016
Earlier this year, we highlighted a new QuintilesIMS Institute research brief that, for the first time, looked at Part D costs after accounting for rebates.   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates